BYETTA Side Effects

6975821-1 | Congestive Cardiomyopathy, Pneumonia, Weight Decreased
on Sep 02, 2010 Male patient from UNITED STATES , 55 years of age, weighting 264.0 lb, was diagnosed with type 2 diabetes mellitus and was treated with Byetta (View Usage). Patient experienced the following unwanted or unexpected effects: congestive cardiomyopathy, pneumonia (What is pneumonia?), weight decreased. Byetta dosage: 5 Ug, 2/d. During the same period patient was treated with ACTOS (30 Mg, Daily (1/d)) (View Actos Review and Actos Label ), GLUCOVANCE (View Glucovance Review and Glucovance Label ). Patient was hospitalized.

6975819-3 | Cellulitis, Growth Hormone Deficiency, Off Label Use, Renal Failure Chronic
Patient was taking Byetta (View Usage). Patient had the following side effects: cellulitis (What is cellulitis?), growth hormone deficiency, off label use, renal failure chronic on Aug 30, 2010 from UNITED STATES Additional patient health information: Male patient , weighting 375.9 lb, . Byetta dosage: 5 Ug, 2/d. During the same period patient was treated with FLOMAX (0.4 Mg, Daily (1/d)) (View Flomax Review and Flomax Label ), TARKA (180 Mg, Daily (1/d)) (View Tarka Review and Tarka Label ), LOVAZA (View Lovaza Review and Lovaza Label ), GLUMETZA (1000 Mg, 2/d) (View Glumetza Review and Glumetza Label ), DIOVAN (320 Mg, Daily (1/d)) (View Diovan Review and Diovan Label ), NEXIUM (40 Mg, Daily (1/d)) (View Nexium Review and Nexium Label ), HYDROCHLOROTHIAZIDE (25 Mg, Daily (1/d)) (View Hydrochlorothiazide Review and Hydrochlorothiazide Label ). Patient was hospitalized.

6975816-8 | Gastrointestinal Haemorrhage, Melaena, Off Label Use, Rectal Haemorrhage, Weight Decreased
Adverse event was reported on Sep 02, 2010 by a Male patient taking Byetta (View Usage) (Dosage: 5 Ug, 2/d) was diagnosed with type 2 diabetes mellitus, hypertension, mineral supplementation, atrial fibrillation (What is atrial fibrillation?) and. Location: UNITED STATES , weighting 312.9 lb, After Byetta was administered, patient had the following side effects: gastrointestinal haemorrhage, melaena, off label use, rectal haemorrhage, weight decreased. During the same period patient was treated with METFORMIN (1000 Mg, 2/d) (View Metformin Review and Metformin Label ), LASIX (40 Mg, Daily (1/d)) (View Lasix Review and Lasix Label ), KLOR CON (20 Meq, Daily (1/d)) (View Klor-con Review and Klor-con Label ), NIFEDIPINE (60 Mg, Daily (1/d)) (View Nifedipine Review and Nifedipine Label ), ASPIRIN (Unk, Daily (1/d)) (View Aspirin Review and Aspirin Label ), ATENOLOL (150 Mg, Daily (1/d)) (View Atenolol Review and Atenolol Label ), DILTIAZEM (Unk, Daily (1/d)) (View Diltiazem Review and Diltiazem Label ). Patient was hospitalized.

6972459-7 | Arterial Occlusive Disease, Blood Glucose Increased, Off Label Use
on Sep 02, 2010 Male patient from UNITED STATES , weighting 318.0 lb, was diagnosed with type 2 diabetes mellitus, cardiac disorder and was treated with Byetta (View Usage). Patient experienced the following unwanted or unexpected effects: arterial occlusive disease, blood glucose increased, off label use. Byetta dosage: . During the same period patient was treated with SYMLIN (15 Ug, 3/d) (View Symlin Review and Symlin Label ), NOVOLOG (View Novolog Review and Novolog Label ). Patient was hospitalized.


6972406-8 | Abnormal Behaviour, Blood Cholesterol Increased, Blood Glucose Increased, Blood Triglycerides Increased, Fall, Gastrooesophageal Reflux Disease, Head Injury, Hiatus Hernia, Hypoglycaemia
on Aug 27, 2010 Female patient from UNITED STATES , weighting 181.0 lb, was diagnosed with type 2 diabetes mellitus, hypertension, asthma (What is asthma?) and was treated with Byetta (View Usage). Patient had the following side effects: abnormal behaviour, blood cholesterol increased, blood glucose increased, blood triglycerides increased, fall (What is fall?), gastrooesophageal reflux disease, head injury, hiatus hernia, hypoglycaemia. Byetta dosage: 10 Ug, 2/d. During the same period patient was treated with CARDIZEM (240 Mg, Unk) (View Cardizem Review and Cardizem Label ), LISINOPRIL (10 Mg, Unk) (View Lisinopril Review and Lisinopril Label ), ADVAIR DISKUS 100/50 (View Advair Diskus 100/50 Review and Advair Diskus 100/50 Label ), SINGULAIR (View Singulair Review and Singulair Label ), PROVENTIL /USA/ (View Proventil /usa/ Review and Proventil /usa/ Label ), ALBUTEROL (View Albuterol Review and Albuterol Label ), XANAX (0.25 Unk, Unk) (View Xanax Review and Xanax Label ).

6972404-4 | Hyperglycaemia
Patient was taking Byetta (View Usage). After Byetta was administered, patient had the following side effects: hyperglycaemia on Sep 01, 2010 from PAKISTAN Additional patient health information: Male patient , 52 years of age, was diagnosed with diabetes mellitus and. Byetta dosage: 10 Ug, Unk. During the same period patient was treated with GLUCOPHAGE (500 Mg, 3/d) (View Glucophage Review and Glucophage Label ), HUMULIN R (Unk, Other) (View Humulin R Review and Humulin R Label ), HUMULIN 70/30 (45 U, Each Morning) (View Humulin 70/30 Review and Humulin 70/30 Label ). Patient was hospitalized.

6972402-0 | Pancreatic Neoplasm, Weight Decreased
Adverse event was reported on Sep 01, 2010 by a Female patient taking Byetta (View Usage) (Dosage: 10 Ug, Daily (1/d)) was diagnosed with diabetes mellitus and. Location: FRANCE , 52 years of age, Patient experienced the following unwanted or unexpected effects: pancreatic neoplasm, weight decreased. Patient was hospitalized.

6967478-0 | Blood Testosterone Decreased, Chest Pain, Myocardial Infarction, Prostate Cancer, Vomiting
on Aug 31, 2010 Male patient from UNITED STATES , weighting 230.0 lb, was diagnosed with type 2 diabetes mellitus, depression (What is depression?), blood pressure increased, blood cholesterol and was treated with Byetta (View Usage). Patient had the following side effects: blood testosterone decreased, chest pain (What is chest pain?), myocardial infarction, prostate cancer (What is prostate cancer?), vomiting. Byetta dosage: 5 Ug, 2/d. During the same period patient was treated with METFORMIN (1000 Mg, 2/d) (View Metformin Review and Metformin Label ), GLIPIZIDE (20 Mg, 2/d) (View Glipizide Review and Glipizide Label ), WELLBUTRIN (View Wellbutrin Review and Wellbutrin Label ), PAXIL (View Paxil Review and Paxil Label ), ENALAPRIL (View Enalapril Review and Enalapril Label ), SIMVASTATIN (View Simvastatin Review and Simvastatin Label ). Patient was hospitalized.

6967429-9 | Anxiety, Cardiac Failure Congestive, Dyspnoea, Heart Rate Decreased, Heart Rate Increased, Hyperhidrosis, Pruritus, Stress
on Aug 27, 2010 Female patient from UNITED STATES , weighting 220.0 lb, was diagnosed with diabetes mellitus, anxiety (What is anxiety?) and was treated with Byetta (View Usage). After Byetta was administered, patient had the following side effects: anxiety (What is anxiety?), cardiac failure congestive, dyspnoea, heart rate decreased, heart rate increased, hyperhidrosis, pruritus, stress (What is stress?). Byetta dosage: 5 Ug, 2/d. During the same period patient was treated with XANAX (1 Mg, Daily (1/d)) (View Xanax Review and Xanax Label ). Patient was hospitalized.

6966748-X | Anxiety, Blood Glucose Increased, Depression, Paranoia, Sleep Apnoea Syndrome, Weight Increased
Patient was taking Byetta (View Usage). Patient experienced the following unwanted or unexpected effects: anxiety (What is anxiety?), blood glucose increased, depression (What is depression?), paranoia, sleep apnoea syndrome, weight increased on Aug 25, 2010 from UNITED STATES Additional patient health information: Female patient , weighting 279.5 lb, was diagnosed with type 2 diabetes mellitus, depression (What is depression?), anxiety (What is anxiety?), blood cholesterol increased, hypersensitivity and. Byetta dosage: 5 Ug, 2/d. During the same period patient was treated with PROZAC (40 Mg, Daily (1/d)) (View Prozac Review and Prozac Label ), METFORMIN (1000 Mg, 2/d) (View Metformin Review and Metformin Label ), JANUVIA (100 Mg, Each Morning) (View Januvia Review and Januvia Label ), KLONOPIN (0.5 Mg, As Needed) (View Klonopin Review and Klonopin Label ), SIMVASTATIN (40 Mg, Each Evening) (View Simvastatin Review and Simvastatin Label ), SINGULAIR (Unk, Daily (1/d)) (View Singulair Review and Singulair Label ), LORATADINE (10 Mg, As Needed) (View Loratadine Review and Loratadine Label ). Patient was hospitalized.

6964955-3 | Blood Glucose Decreased, Blood Glucose Increased, Fatigue, Leukaemia, Nausea, Off Label Use, Weight Decreased
Adverse event was reported on Aug 30, 2010 by a Female patient taking Byetta (View Usage) (Dosage: 5 Ug, 2/d) was diagnosed with type 2 diabetes mellitus and. Location: UNITED STATES , weighting 158.0 lb, Patient had the following side effects: blood glucose decreased, blood glucose increased, fatigue, leukaemia, nausea (What is nausea?), off label use, weight decreased. During the same period patient was treated with GLUCOPHAGE (1000 Mg, 2/d) (View Glucophage Review and Glucophage Label ), LEVEMIR (12 U, Daily (1/d)) (View Levemir Review and Levemir Label ).

6964947-4 | Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Off Label Use, Pancreatitis, Weight Decreased
on Aug 27, 2010 Female patient from UNITED STATES , 55 years of age, weighting 210.0 lb, was diagnosed with type 2 diabetes mellitus, hypertension, gastrooesophageal reflux disease and was treated with Byetta (View Usage). After Byetta was administered, patient had the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, off label use, pancreatitis, weight decreased. Byetta dosage: . During the same period patient was treated with LANTUS (Unk U, Daily (1/d)) (View Lantus Review and Lantus Label ), ACTOS (30 Mg, Daily (1/d)) (View Actos Review and Actos Label ), METFORMIN (View Metformin Review and Metformin Label ), AMARYL (2 Mg, Daily (1/d)) (View Amaryl Review and Amaryl Label ), CATAPRES /UNK/ (1 D/f, Each Morning) (View Catapres /unk/ Review and Catapres /unk/ Label ), HYDROCHLOROTHIAZIDE (20 Mg, 3/d) (View Hydrochlorothiazide Review and Hydrochlorothiazide Label ), PRILOSEC (20 Mg, Daily (1/d)) (View Prilosec Review and Prilosec Label ). Patient was hospitalized.

6964910-3 | Abdominal Pain Upper, Adrenal Cyst, Blood Cholesterol Increased, Hepatic Steatosis, Hepatomegaly, Hypertension, Pancreatitis, Weight Decreased
on Aug 26, 2010 Female patient from UNITED STATES , weighting 155.0 lb, was diagnosed with type 2 diabetes mellitus, multiple allergies and was treated with Byetta (View Usage). Patient experienced the following unwanted or unexpected effects: abdominal pain upper, adrenal cyst, blood cholesterol increased, hepatic steatosis, hepatomegaly, hypertension, pancreatitis, weight decreased. Byetta dosage: 5 Ug, Unk. During the same period patient was treated with METFORMIN (500 Mg, Each Morning) (View Metformin Review and Metformin Label ), ALBUTEROL (180 Ug, As Needed) (View Albuterol Review and Albuterol Label ), FEXOFENADINE HCL (60 Mg, 2/d) (View Fexofenadine Hcl Review and Fexofenadine Hcl Label ), FLUTICASONE PROPIONATE (100 Ug, 2/d) (View Fluticasone Propionate Review and Fluticasone Propionate Label ), LISINOPRIL (20 Mg, Daily (1/d)) (View Lisinopril Review and Lisinopril Label ).

6964909-7 | Chondropathy, Feeling Cold, Muscle Twitching, Scar Excision
Patient was taking Byetta (View Usage). Patient had the following side effects: chondropathy, feeling cold, muscle twitching, scar excision on Aug 25, 2010 from UNITED STATES Additional patient health information: Female patient , weighting 195.0 lb, was diagnosed with type 2 diabetes mellitus and. Byetta dosage: 5 Ug, 2/d. During the same period patient was treated with LEVOXYL (Unk, Daily (1/d)) (View Levoxyl Review and Levoxyl Label ), RAMIPRIL (Unk, Daily (1/d)) (View Ramipril Review and Ramipril Label ). Patient was hospitalized.

6964907-3 | Abdominal Pain, Pancreatitis
Adverse event was reported on Aug 26, 2010 by a Female patient taking Byetta (View Usage) (Dosage: 5 Ug, 2/d) was diagnosed with type 2 diabetes mellitus and. Location: UNITED STATES , weighting 180.0 lb, After Byetta was administered, patient had the following side effects: abdominal pain (What is abdominal pain?), pancreatitis. Patient was hospitalized.

6964895-X | Renal Failure Acute, Weight Decreased
on Aug 23, 2010 Male patient from UNITED KINGDOM , 54 years of age, weighting 326.3 lb, was treated with Byetta (View Usage). Patient experienced the following unwanted or unexpected effects: renal failure acute, weight decreased. Byetta dosage: 5 Ug, 2/d. During the same period patient was treated with AMLODIPINE (View Amlodipine Review and Amlodipine Label ), ATORVASTATIN (View Atorvastatin Review and Atorvastatin Label ), CITALOPRAM HYDROBROMIDE (View Citalopram Hydrobromide Review and Citalopram Hydrobromide Label ), GLICLAZIDE (View Gliclazide Review and Gliclazide Label ), INDAPAMIDE (View Indapamide Review and Indapamide Label ), METFORMIN (View Metformin Review and Metformin Label ), RAMIPRIL (View Ramipril Review and Ramipril Label ). Patient was hospitalized.

6964884-5 | Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased
on Aug 24, 2010 Female patient from UNITED STATES , 82 years of age, was diagnosed with diabetes mellitus and was treated with Byetta (View Usage). Patient had the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased. Byetta dosage: . During the same period patient was treated with TRICOR (View Tricor Review and Tricor Label ).

6963028-3 | Arthralgia, Blood Glucose Increased, Fall, Gait Disturbance, Joint Injury, Joint Swelling, Oedema Peripheral, Walking Aid User
Patient was taking Byetta (View Usage). After Byetta was administered, patient had the following side effects: arthralgia, blood glucose increased, fall (What is fall?), gait disturbance, joint injury, joint swelling, oedema peripheral, walking aid user on Aug 23, 2010 from UNITED STATES Additional patient health information: Female patient , weighting 259.9 lb, was diagnosed with type 2 diabetes mellitus, hypertension and. Byetta dosage: 5 Ug, 2/d. During the same period patient was treated with ACTOS /SCH/ (30 Mg, Daily (1/d)) (View Actos /sch/ Review and Actos /sch/ Label ), DILTIAZEM (180 Mg, Daily (1/d)) (View Diltiazem Review and Diltiazem Label ), BENICAR HCT (1 D/f, Daily (1/d)) (View Benicar Hct Review and Benicar Hct Label ), VITAMINS (View Vitamins Review and Vitamins Label ). Patient was hospitalized.

6963027-1 | Attention Deficit/hyperactivity Disorder, Blood Glucose Increased, Eye Swelling, Retinal Haemorrhage, Retinal Vein Occlusion, Stress, Vision Blurred, Visual Acuity Reduced
Adverse event was reported on Aug 23, 2010 by a Female patient taking Byetta (View Usage) (Dosage: 5 Ug, 2/d) was diagnosed with type 2 diabetes mellitus, anxiety (What is anxiety?), hypertension, urinary incontinence (What is urinary incontinence?), gastrooesophageal reflux disease and. Location: UNITED STATES , weighting 210.0 lb, Patient experienced the following unwanted or unexpected effects: attention deficit/hyperactivity disorder, blood glucose increased, eye swelling, retinal haemorrhage, retinal vein occlusion, stress (What is stress?), vision blurred, visual acuity reduced. During the same period patient was treated with CYMBALTA (60 Mg, Daily (1/d)) (View Cymbalta Review and Cymbalta Label ), TRICOR (145 Mg, Daily (1/d)) (View Tricor Review and Tricor Label ), CADUET (40 D/f, Daily (1/d)) (View Caduet Review and Caduet Label ), DETROL LA (4 Mg, Daily (1/d)) (View Detrol La Review and Detrol La Label ), NEXIUM (40 Mg, Daily (1/d)) (View Nexium Review and Nexium Label ), FOSINOPRIL SODIUM (25 Mg, Daily (1/d)) (View Fosinopril Sodium Review and Fosinopril Sodium Label ), GLIMEPIRIDE (4 Mg, Daily (1/d)) (View Glimepiride Review and Glimepiride Label ).

6963022-2 | Diarrhoea, Renal Impairment
on Aug 23, 2010 Male patient from UNITED KINGDOM , weighting 229.9 lb, was diagnosed with diabetes mellitus inadequate control, hypertension, blood cholesterol increased and was treated with Byetta (View Usage). Patient had the following side effects: diarrhoea, renal impairment. Byetta dosage: 5 Ug, 2/d. During the same period patient was treated with RAMIPRIL (10 Mg, Daily (1/d)) (View Ramipril Review and Ramipril Label ), SIMVASTATIN (40 Mg, Daily (1/d)) (View Simvastatin Review and Simvastatin Label ), IRBESARTAN (300 Mg, Daily (1/d)) (View Irbesartan Review and Irbesartan Label ), AMLODIPINE (5 Mg, Daily (1/d)) (View Amlodipine Review and Amlodipine Label ), BENDROFLUAZIDE (2.5 Mg, Daily (1/d)) (View Bendrofluazide Review and Bendrofluazide Label ), PIOGLITAZONE (15 Mg, Daily (1/d)) (View Pioglitazone Review and Pioglitazone Label ).

6963020-9 | Anaemia, Cystitis, Nephrolithiasis, Off Label Use, Pain, Urinary Tract Obstruction
on Aug 23, 2010 Female patient from UNITED STATES , weighting 250.0 lb, was diagnosed with type 2 diabetes mellitus, asthma (What is asthma?), depression (What is depression?), incontinence and was treated with Byetta (View Usage). After Byetta was administered, patient had the following side effects: anaemia, cystitis, nephrolithiasis, off label use, pain (What is pain?), urinary tract obstruction. Byetta dosage: 5 Ug, 2/d. During the same period patient was treated with LANTUS (20 D/f, Unk) (View Lantus Review and Lantus Label ), METFORMIN (1000 Mg, 2/d) (View Metformin Review and Metformin Label ), JANUVIA (100 Mg, Daily (1/d)) (View Januvia Review and Januvia Label ), ALBUTEROL (4 Mg, 2/d) (View Albuterol Review and Albuterol Label ), CITALOPRAM HYDROBROMIDE (20 Mg, Daily (1/d)) (View Citalopram Hydrobromide Review and Citalopram Hydrobromide Label ), TOVIAZ (8 Mg, Each Evening) (View Toviaz Review and Toviaz Label ), RISPERIDONE (2 Mg, Unk) (View Risperidone Review and Risperidone Label ). Patient was hospitalized.

6960258-1 | Arteriosclerosis Coronary Artery, Ascites, Atelectasis, Blood Glucose Increased, Cholecystitis Acute, Cholelithiasis, Decreased Appetite, Gastritis Haemorrhagic, Hepatic Steatosis
Patient was taking Byetta (View Usage). Patient experienced the following unwanted or unexpected effects: arteriosclerosis coronary artery, ascites, atelectasis, blood glucose increased, cholecystitis acute, cholelithiasis, decreased appetite, gastritis haemorrhagic, hepatic steatosis on Aug 27, 2010 from UNITED STATES Additional patient health information: Male patient , 47 years of age, weighting 443.9 lb, was diagnosed with type 2 diabetes mellitus and. Byetta dosage: 5 Mg, 2/d. During the same period patient was treated with LISINOPRIL (View Lisinopril Review and Lisinopril Label ), METFORMIN (View Metformin Review and Metformin Label ), VYTORIN (Unk, Unk) (View Vytorin Review and Vytorin Label ), CLARITIN (Unk, Unk) (View Claritin Review and Claritin Label ). Patient was hospitalized.

6960250-7 | Arthralgia, Blood Glucose Increased, Fall, Gait Disturbance, Groin Pain, Joint Injury, Joint Swelling, Oedema Peripheral
Adverse event was reported on Aug 23, 2010 by a Female patient taking Byetta (View Usage) (Dosage: 5 Ug, 2/d) was diagnosed with type 2 diabetes mellitus, hypertension and. Location: UNITED STATES , weighting 259.9 lb, Patient had the following side effects: arthralgia, blood glucose increased, fall (What is fall?), gait disturbance, groin pain, joint injury, joint swelling, oedema peripheral. During the same period patient was treated with ACTOS /SCH/ (30 Mg, Daily (1/d)) (View Actos /sch/ Review and Actos /sch/ Label ), DILTIAZEM (180 Mg, Daily (1/d)) (View Diltiazem Review and Diltiazem Label ), BENICAR HCT (1 D/f, Daily (1/d)) (View Benicar Hct Review and Benicar Hct Label ), VITAMINS (View Vitamins Review and Vitamins Label ). Patient was hospitalized.

6960239-8 | Blood Glucose Increased, Blood Potassium Decreased, Cerebrovascular Accident, Concussion, Neck Pain, Off Label Use, Renal Impairment, Road Traffic Accident, Urinary Tract Infection Bacterial
on Aug 20, 2010 Male patient from UNITED STATES , weighting 273.9 lb, was diagnosed with type 2 diabetes mellitus and was treated with Byetta (View Usage). After Byetta was administered, patient had the following side effects: blood glucose increased, blood potassium decreased, cerebrovascular accident, concussion (What is concussion?), neck pain, off label use, renal impairment, road traffic accident, urinary tract infection bacterial. Byetta dosage: 5 Ug, 2/d. During the same period patient was treated with METFORMIN (2000 Mg, Daily (1/d)) (View Metformin Review and Metformin Label ), GLIMEPIRIDE (4 Mg, 2/d) (View Glimepiride Review and Glimepiride Label ), LISINOPRIL (20 Mg, 2/d) (View Lisinopril Review and Lisinopril Label ), SIMVASTATIN (20 Mg, Daily (1/d)) (View Simvastatin Review and Simvastatin Label ), AMLODIPINE (10 Mg, Daily (1/d)) (View Amlodipine Review and Amlodipine Label ), ASPIRIN (325 Mg, Daily (1/d)) (View Aspirin Review and Aspirin Label ), MULTI VITAMIN (Unk, Daily (1/d)) (View Multi-vitamin Review and Multi-vitamin Label ). Patient was hospitalized.

6960236-2 | Pancreatitis, Weight Decreased, Weight Increased
on Aug 23, 2010 Male patient from UNITED STATES , 39 years of age, weighting 240.0 lb, was diagnosed with type 2 diabetes mellitus, hypertension, hyperlipidaemia, gastrooesophageal reflux disease and was treated with Byetta (View Usage). Patient experienced the following unwanted or unexpected effects: pancreatitis, weight decreased, weight increased. Byetta dosage: 10 Ug, 2/d. During the same period patient was treated with METFORMIN (1000 Mg, 2/d) (View Metformin Review and Metformin Label ), ASPIRIN (81 Mg, Daily (1/d)) (View Aspirin Review and Aspirin Label ), LIPITOR (20 Mg, Daily (1/d)) (View Lipitor Review and Lipitor Label ), LISINOPRIL (20 Mg, Daily (1/d)) (View Lisinopril Review and Lisinopril Label ), PROTONIX (40 Mg, Daily (1/d)) (View Protonix Review and Protonix Label ). Patient was hospitalized.

6958842-4 | Blood Glucose Increased, Cataract, Dyspnoea, Nausea, Off Label Use, Pulmonary Hypertension, Sleep Apnoea Syndrome
Patient was taking Byetta (View Usage). Patient had the following side effects: blood glucose increased, cataract (What is cataract?), dyspnoea, nausea (What is nausea?), off label use, pulmonary hypertension (What is pulmonary hypertension?), sleep apnoea syndrome on Aug 17, 2010 from UNITED STATES Additional patient health information: Female patient , weighting 252.0 lb, was diagnosed with type 2 diabetes mellitus, thyroid disorder and. Byetta dosage: . During the same period patient was treated with LANTUS (70 U, Each Evening) (View Lantus Review and Lantus Label ), THYROID TAB (View Thyroid Tab Review and Thyroid Tab Label ), SYNTHROID (View Synthroid Review and Synthroid Label ).

6957553-9 | Cardiac Disorder
Adverse event was reported on Aug 23, 2010 by a Female patient taking Byetta (View Usage) (Dosage: ) . Location: UNITED STATES , 80 years of age, After Byetta was administered, patient had the following side effects: cardiac disorder. Patient was hospitalized.

6957552-7 | Blood Glucose Increased, Eye Haemorrhage, Off Label Use, Retinal Injury, Retinal Scar, Retinopathy, Visual Acuity Reduced
on Aug 20, 2010 Female patient from UNITED STATES , 54 years of age, weighting 170.0 lb, was diagnosed with type 1 diabetes mellitus and was treated with Byetta (View Usage). Patient experienced the following unwanted or unexpected effects: blood glucose increased, eye haemorrhage, off label use, retinal injury, retinal scar, retinopathy, visual acuity reduced. Byetta dosage: 10 Ug, 2/d. During the same period patient was treated with HUMULIN /00646001/ (View Humulin /00646001/ Review and Humulin /00646001/ Label ).

6957548-5 | Anaesthesia, Mastectomy, Phlebitis, Thrombosis
on Aug 20, 2010 Female patient from UNITED STATES , weighting 170.0 lb, was diagnosed with type 2 diabetes mellitus, insulin resistant diabetes and was treated with Byetta (View Usage). Patient had the following side effects: anaesthesia, mastectomy (What is mastectomy?), phlebitis, thrombosis. Byetta dosage: 5 Ug, 2/d. During the same period patient was treated with METFORMIN (2000 Mg, 2/d) (View Metformin Review and Metformin Label ). Patient was hospitalized.

6957544-8 | Pancreatitis Acute
Patient was taking Byetta (View Usage). After Byetta was administered, patient had the following side effects: pancreatitis acute on Aug 20, 2010 from FRANCE Additional patient health information: Female patient , 57 years of age, weighting 194.0 lb, was diagnosed with type 2 diabetes mellitus, dyslipidaemia, hypertension, nausea (What is nausea?) and. Byetta dosage: . During the same period patient was treated with DIAMICRON (30 Mg, 4/d) (View Diamicron Review and Diamicron Label ), METFORMIN HCL (500 Mg, 3/d) (View Metformin Hcl Review and Metformin Hcl Label ), TAHOR (40 Mg, Daily (1/d)) (View Tahor Review and Tahor Label ), VALSARTAN AND HYDROCHLOROTHIAZIDE (1 D/f, Daily (1/d)) (View Valsartan And Hydrochlorothiazide Review and Valsartan And Hydrochlorothiazide Label ), ACEBUTOLOL (200 Mg, 2/d) (View Acebutolol Review and Acebutolol Label ), KARDEGIC (160 Mg, Daily (1/d)) (View Kardegic Review and Kardegic Label ), AMLODIPINE (10 Mg, Daily (1/d)) (View Amlodipine Review and Amlodipine Label ), BIPERIDYS (Unk, As Needed) (View Biperidys Review and Biperidys Label ). Patient was hospitalized.

6957542-4 | Blood Creatinine Increased, Blood Urea Increased, Pancreatitis, Weight Decreased
Adverse event was reported on Aug 20, 2010 by a Male patient taking Byetta (View Usage) (Dosage: ) was diagnosed with type 2 diabetes mellitus, hyperlipidaemia and. Location: UNITED STATES , weighting 223.0 lb, Patient experienced the following unwanted or unexpected effects: blood creatinine increased, blood urea increased, pancreatitis, weight decreased. During the same period patient was treated with HYDROCHLOROTHIAZIDE (View Hydrochlorothiazide Review and Hydrochlorothiazide Label ), LIPITOR (View Lipitor Review and Lipitor Label ), CARVEDILOL (View Carvedilol Review and Carvedilol Label ), AVAPRO (View Avapro Review and Avapro Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), AMARYL (View Amaryl Review and Amaryl Label ), SYNTHROID (View Synthroid Review and Synthroid Label ), VITAMIN B 12 (View Vitamin B-12 Review and Vitamin B-12 Label ).

6957538-2 | Blood Triglycerides Increased, Crohn's Disease, Depression, Diarrhoea, Haematochezia, Off Label Use, Thyroid Disorder, Vomiting
on Aug 19, 2010 Female patient from UNITED STATES , weighting 267.9 lb, was diagnosed with fluid retention, asthma (What is asthma?) and was treated with Byetta (View Usage). Patient had the following side effects: blood triglycerides increased, crohn's disease (What is crohn's disease?), depression (What is depression?), diarrhoea, haematochezia, off label use, thyroid disorder, vomiting. Byetta dosage: 5 Ug, 2/d. During the same period patient was treated with LANTUS (50 U, Each Evening) (View Lantus Review and Lantus Label ), METFORMIN (1000 Mg, 2/d) (View Metformin Review and Metformin Label ), FUROSEMIDE (20 Mg, Daily (1/d)) (View Furosemide Review and Furosemide Label ), ADVAIR DISKUS 100/50 (View Advair Diskus 100/50 Review and Advair Diskus 100/50 Label ), ALBUTEROL (View Albuterol Review and Albuterol Label ), TOPAMAX (50 Mg, Unk) (View Topamax Review and Topamax Label ). Patient was hospitalized.

6957535-7 | Cholelithiasis
on Aug 19, 2010 Female patient from UNITED STATES , weighting 245.0 lb, was diagnosed with type 2 diabetes mellitus and was treated with Byetta (View Usage). After Byetta was administered, patient had the following side effects: cholelithiasis. Byetta dosage: 5 Ug, 2/d. During the same period patient was treated with METFORMIN (1000 Mg, 2/d) (View Metformin Review and Metformin Label ). Patient was hospitalized.

6957533-3 | Agitation, Angioedema, Blood Glucose Decreased, Blood Glucose Increased, Dyspnoea, Ear Disorder, Headache, Hyperhidrosis, Malaise
Patient was taking Byetta (View Usage). Patient experienced the following unwanted or unexpected effects: agitation, angioedema, blood glucose decreased, blood glucose increased, dyspnoea, ear disorder, headache (What is headache?), hyperhidrosis, malaise on Aug 20, 2010 from UNITED STATES Additional patient health information: Female patient , weighting 230.0 lb, was diagnosed with type 2 diabetes mellitus and. Byetta dosage: 5 Ug, 2/d. During the same period patient was treated with METFORMIN (View Metformin Review and Metformin Label ), PRANDIN (2 Mg, 2/d) (View Prandin Review and Prandin Label ), FISH OIL (View Fish Oil Review and Fish Oil Label ). Patient was hospitalized.

6942519-5 | Blood Glucose Decreased, Blood Glucose Increased, Decreased Appetite, Dehydration, Hypophagia, Off Label Use, Overdose, Renal Failure, Vomiting
Adverse event was reported on Aug 18, 2010 by a Male patient taking Byetta (View Usage) (Dosage: 5 Ug, 2/d) was diagnosed with type 2 diabetes mellitus and. Location: UNITED STATES , weighting 249.0 lb, Patient had the following side effects: blood glucose decreased, blood glucose increased, decreased appetite, dehydration, hypophagia, off label use, overdose, renal failure, vomiting. During the same period patient was treated with METFORMIN (View Metformin Review and Metformin Label ), JANUVIA (View Januvia Review and Januvia Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ), LISINOPRIL (View Lisinopril Review and Lisinopril Label ), GLIPIZIDE (6 Mg, 2/d) (View Glipizide Review and Glipizide Label ). Patient was hospitalized.

6942517-1 | Hepatitis Toxic
on Aug 19, 2010 Female patient from BELGIUM , weighting 189.6 lb, was diagnosed with type 2 diabetes mellitus, musculoskeletal pain and was treated with Byetta (View Usage). After Byetta was administered, patient had the following side effects: hepatitis toxic. Byetta dosage: 10 Ug, Unk. During the same period patient was treated with ACETAMINOPHEN (View Acetaminophen Review and Acetaminophen Label ), GLUCOPHAGE (View Glucophage Review and Glucophage Label ), GLUCOVANCE (View Glucovance Review and Glucovance Label ), ALDACTAZINE (View Aldactazine Review and Aldactazine Label ), AMLODIPINE (View Amlodipine Review and Amlodipine Label ), CRESTOR (View Crestor Review and Crestor Label ), ASAFLOW (View Asaflow Review and Asaflow Label ). Patient was hospitalized.

6942514-6 | Asthma, Back Pain, Hyperglycaemia, Off Label Use, Pancreatitis Acute, Weight Decreased
on Aug 17, 2010 Male patient from UNITED KINGDOM , 45 years of age, weighting 280.0 lb, was diagnosed with diabetes mellitus and was treated with Byetta (View Usage). Patient experienced the following unwanted or unexpected effects: asthma (What is asthma?), back pain (What is back pain?), hyperglycaemia, off label use, pancreatitis acute, weight decreased. Byetta dosage: 10 Ug, 2/d. During the same period patient was treated with AMITRIPTYLINE HCL (View Amitriptyline Hcl Review and Amitriptyline Hcl Label ), AMLODIPINE (View Amlodipine Review and Amlodipine Label ), ATORVASTATIN (View Atorvastatin Review and Atorvastatin Label ), BECLOMETHASONE DIPROPIONATE (1 D/f, 2/d) (View Beclomethasone Dipropionate Review and Beclomethasone Dipropionate Label ), GABAPENTIN (600 Mg, 3/d) (View Gabapentin Review and Gabapentin Label ), GLUCOSAMINE (500 Mg, 3/d) (View Glucosamine Review and Glucosamine Label ), IPRATROPIUM BROMIDE (View Ipratropium Bromide Review and Ipratropium Bromide Label ), LANSOPRAZOLE (30 Mg, 2/d) (View Lansoprazole Review and Lansoprazole Label ).

6940251-5 | Aspiration, Knee Arthroplasty, Nausea, Oxygen Saturation Decreased, Pneumonia Aspiration, Transfusion
Patient was taking Byetta (View Usage). Patient had the following side effects: aspiration, knee arthroplasty, nausea (What is nausea?), oxygen saturation decreased, pneumonia aspiration, transfusion on Aug 16, 2010 from UNITED STATES Additional patient health information: Female patient , weighting 152.0 lb, was diagnosed with type 2 diabetes mellitus and. Byetta dosage: 10 Ug, Daily (1/d). During the same period patient was treated with GLUCOPHAGE (View Glucophage Review and Glucophage Label ). Patient was hospitalized.

6940242-4 | Intervertebral Disc Protrusion, Pain In Extremity, Weight Bearing Difficulty
Adverse event was reported on Aug 16, 2010 by a Male patient taking Byetta (View Usage) (Dosage: 5 Ug, 2/d) was diagnosed with type 2 diabetes mellitus and. Location: UNITED STATES , weighting 309.9 lb, After Byetta was administered, patient had the following side effects: intervertebral disc protrusion, pain in extremity, weight bearing difficulty. During the same period patient was treated with METFORMIN HCL (4 D/f, Daily (1/d)) (View Metformin Hcl Review and Metformin Hcl Label ), GLIMEPIRIDE (View Glimepiride Review and Glimepiride Label ). Patient was hospitalized.

6940232-1 | Abdominal Pain Upper, Asthenia, Decreased Appetite, Hyperhidrosis, Injury, Laboratory Test Abnormal, Malaise, Nausea, Pancreatitis
on Aug 17, 2010 Female patient from UNITED STATES , weighting 200.0 lb, was diagnosed with type 2 diabetes mellitus, hypertension, dyspepsia and was treated with Byetta (View Usage). Patient experienced the following unwanted or unexpected effects: abdominal pain upper, asthenia, decreased appetite, hyperhidrosis, injury, laboratory test abnormal, malaise, nausea (What is nausea?), pancreatitis. Byetta dosage: 5 Ug, 2/d. During the same period patient was treated with GLIPIZIDE (View Glipizide Review and Glipizide Label ), METFORMIN (View Metformin Review and Metformin Label ), LOVASTATIN (View Lovastatin Review and Lovastatin Label ), CAPTOPRIL (View Captopril Review and Captopril Label ), OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ), ASPIRIN (Unk, Daily (1/d)) (View Aspirin Review and Aspirin Label ).

6940230-8 | Blood Glucose Increased, Blood Pressure Increased, Carotid Artery Disease, Lethargy, Nausea, Off Label Use, Stent Placement
on Aug 16, 2010 Female patient from UNITED STATES , weighting 155.0 lb, was diagnosed with type 2 diabetes mellitus, hypertension, stress (What is stress?) and was treated with Byetta (View Usage). Patient had the following side effects: blood glucose increased, blood pressure increased, carotid artery disease (What is carotid artery disease?), lethargy, nausea (What is nausea?), off label use, stent placement. Byetta dosage: 10 Ug, As Needed. During the same period patient was treated with ACTOPLUS MET (View Actoplus Met Review and Actoplus Met Label ), LANTUS /01483501/ (View Lantus /01483501/ Review and Lantus /01483501/ Label ), LISINOPRIL (View Lisinopril Review and Lisinopril Label ), CLONAZEPAM (Unk, As Needed) (View Clonazepam Review and Clonazepam Label ), ESTRADERM (View Estraderm Review and Estraderm Label ), PLAVIX (View Plavix Review and Plavix Label ). Patient was hospitalized.

6940188-1 | Glomerular Filtration Rate Decreased
Patient was taking Byetta (View Usage). After Byetta was administered, patient had the following side effects: glomerular filtration rate decreased on Aug 16, 2010 from UNITED KINGDOM Additional patient health information: Male patient , 66 years of age, weighting 293.2 lb, was diagnosed with diabetes mellitus, hypertension, hypercholesterolaemia and. Byetta dosage: 5 Ug, Unk. During the same period patient was treated with GLICLAZIDE (160 Mg, 2/d) (View Gliclazide Review and Gliclazide Label ), ATENOLOL (50 Mg, Unk) (View Atenolol Review and Atenolol Label ), FUROSEMIDE (40 Mg, Unk) (View Furosemide Review and Furosemide Label ), SIMVASTATIN (40 Mg, Unk) (View Simvastatin Review and Simvastatin Label ).

6940186-8 | Off Label Use, Syncope
Adverse event was reported on Aug 17, 2010 by a Female patient taking Byetta (View Usage) (Dosage: ) was diagnosed with obesity (What is obesity?) and. Location: COLOMBIA , 25 years of age, Patient experienced the following unwanted or unexpected effects: off label use, syncope.

6940184-4 | Injury, Pancreatitis Acute, Weight Decreased
on Aug 17, 2010 Female patient from UNITED STATES , weighting 178.0 lb, was diagnosed with type 2 diabetes mellitus and was treated with Byetta (View Usage). Patient had the following side effects: injury, pancreatitis acute, weight decreased. Byetta dosage: . Patient was hospitalized.

6938272-1 | Abdominal Pain, Blood Amylase Increased, Lipase Increased, Pancreatitis, Weight Decreased
on Aug 12, 2010 Female patient from UNITED STATES , 48 years of age, weighting 206.0 lb, was diagnosed with type 2 diabetes mellitus, hypertension, hypercholesterolaemia and was treated with Byetta (View Usage). After Byetta was administered, patient had the following side effects: abdominal pain (What is abdominal pain?), blood amylase increased, lipase increased, pancreatitis, weight decreased. Byetta dosage: . During the same period patient was treated with MONOPRIL (40 Mg, Daily (1/d)) (View Monopril Review and Monopril Label ), NORVASC (5 Mg, Daily (1/d)) (View Norvasc Review and Norvasc Label ), GLUCOPHAGE (1000 Mg, 2/d) (View Glucophage Review and Glucophage Label ), TRILIPIX (135 Mg, Daily (1/d)) (View Trilipix Review and Trilipix Label ). Patient was hospitalized.

6938270-8 | Depressed Mood
Patient was taking Byetta (View Usage). Patient experienced the following unwanted or unexpected effects: depressed mood on Aug 13, 2010 from UNITED KINGDOM Additional patient health information: Male patient , 63 years of age, weighting 265.9 lb, was diagnosed with diabetes mellitus and. Byetta dosage: . During the same period patient was treated with AVANDAMET (View Avandamet Review and Avandamet Label ), RAMIPRIL (View Ramipril Review and Ramipril Label ), SIMVASTATIN (View Simvastatin Review and Simvastatin Label ), ASPIRIN (View Aspirin Review and Aspirin Label ).

6938218-6 | Fatigue, Pain In Extremity, Rash Macular
Adverse event was reported on Aug 11, 2010 by a Female patient taking Byetta (View Usage) (Dosage: ) was diagnosed with diabetes mellitus, lipids increased and. Location: UNITED KINGDOM , weighting 235.9 lb, Patient had the following side effects: fatigue, pain in extremity, rash macular. During the same period patient was treated with SIMVASTATIN (View Simvastatin Review and Simvastatin Label ), METFORMIN HCL (View Metformin Hcl Review and Metformin Hcl Label ).

6937714-5 | Abdominal Pain, Pancreatitis, Renal Disorder
on Aug 20, 2010 Male patient from UNITED STATES , 61 years of age, weighting 295.0 lb, was diagnosed with type 2 diabetes mellitus and was treated with Byetta (View Usage). After Byetta was administered, patient had the following side effects: abdominal pain (What is abdominal pain?), pancreatitis, renal disorder. Byetta dosage: (3 Years, 9 Months). During the same period patient was treated with BISOPROLOL (View Bisoprolol Review and Bisoprolol Label ), LISINOPRIL (View Lisinopril Review and Lisinopril Label ), PREVACID (View Prevacid Review and Prevacid Label ), REQUIP (View Requip Review and Requip Label ), PRITIQ (View Pritiq Review and Pritiq Label ), SKELAXIN (View Skelaxin Review and Skelaxin Label ), NABUMETONE (View Nabumetone Review and Nabumetone Label ), FENTORA (View Fentora Review and Fentora Label ). Patient was hospitalized.

6935964-5 | Abdominal Pain, Blood Glucose Increased, Chills, Colitis, Diarrhoea, Malaise, Muscle Spasms, Nasal Congestion
on Aug 11, 2010 Female patient from UNITED STATES , weighting 188.0 lb, was diagnosed with type 2 diabetes mellitus and was treated with Byetta (View Usage). Patient experienced the following unwanted or unexpected effects: abdominal pain (What is abdominal pain?), blood glucose increased, chills, colitis, diarrhoea, malaise, muscle spasms, nasal congestion. Byetta dosage: 5 Ug, 2/d. During the same period patient was treated with METFORMIN (500 Mg, Each Morning) (View Metformin Review and Metformin Label ), GLYBURIDE AND METFORMIN HCL (Unk, 2/d) (View Glyburide And Metformin Hcl Review and Glyburide And Metformin Hcl Label ), HUMULIN R (View Humulin R Review and Humulin R Label ), HUMALOG (17 U, Each Evening) (View Humalog Review and Humalog Label ), SYMLIN (60 Ug, 2/d) (View Symlin Review and Symlin Label ). Patient was hospitalized.

6935959-1 | Cholelithiasis, Pancreatitis Acute
Patient was taking Byetta (View Usage). Patient had the following side effects: cholelithiasis, pancreatitis acute on Aug 12, 2010 from UNITED KINGDOM Additional patient health information: Male patient , 76 years of age, weighting 207.7 lb, was diagnosed with hypertension, dyspepsia and. Byetta dosage: . During the same period patient was treated with ASPIRIN (View Aspirin Review and Aspirin Label ), CANDESARTAN (View Candesartan Review and Candesartan Label ), LANSOPRAZOLE (View Lansoprazole Review and Lansoprazole Label ), METFORMIN (View Metformin Review and Metformin Label ). Patient was hospitalized.